Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL112513 | 1.00 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL110651 | 1.00 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL112512 | 1.00 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL8029779 | 1.00 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL109917 | 1.00 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL5366842 | 1.00 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL112307 | 1.00 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL110652 | 1.00 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL114444 | 1.00 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL114445 | 1.00 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101568350-B | Lipidized interferon and uses thereof | SHEN WEIQIANG | 2013-11-06 | — | — | CN | claimed |
| CN-101568350-A | Lipidized interferon and uses thereof | SHEN WEI CHIANG (US) | 2009-10-28 | — | — | CN | claimed |
| US-20240141017-A1 | FLUORESCENT BIOSENSORS AND METHODS OF USE FOR DETECTING CELL SIGNALING EVENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-05-02 | — | — | US | disclosed |
| EP-4298443-A1 | FLUORESCENT BIOSENSORS AND METHODS OF USE FOR DETECTING CELL SIGNALING EVENTS | The Regents Of The University Of Michigan (US) | 2024-01-03 | — | — | EP | disclosed |
| WO-2022182932-A1 | FLUORESCENT BIOSENSORS AND METHODS OF USE FOR DETECTING CELL SIGNALING EVENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2022-09-01 | — | — | WO | disclosed |
| CN-108430993-A | TANK-BINDING KINASE INHIBITOR COMPOUNDS | 吉利德科学公司 | 2018-08-21 | — | — | CN | disclosed |
| US-20170283455-A1 | STABLE TOPICAL PHAMACEUTICAL COMPOSITIONS OF HALOBETASOL PROPIONATE | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2017-10-05 | — | — | US | disclosed |
| CN-106237316-A | The compositions comprising hemagglutinin, the method manufacturing it and the method using it | 法克斯因内特公司 | 2016-12-21 | — | — | CN | disclosed |
| CN-101568350-B | Lipidized interferon and uses thereof | SHEN WEIQIANG | 2013-11-06 | — | — | CN | disclosed |
| CN-101568350-A | Lipidized interferon and uses thereof | SHEN WEI CHIANG (US) | 2009-10-28 | — | — | CN | disclosed |
| CN-101405401-A | Genetic programming expression of protein containing unnatural amino acid phenylselenocysteine | SCRIPPS RESEARCH INST (US) | 2009-04-08 | — | — | CN | disclosed |
| EP-1575900-A4 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LT (AU) | 2007-02-21 | — | — | EP | disclosed |
| CN-1791675-A | Viral vectors expressing fusion of viral large envelope protein and protein of interest | HEPGENICS PTY LTD (AU) | 2006-06-21 | — | — | CN | disclosed |
| EP-1575900-A1 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LTD (AU) | 2005-09-21 | — | — | EP | disclosed |
| CN-1192101-C | Production of the lipidated form of the peptido glycon-associated lipoproteins of gram-negative bacteria | WYETH CORP (US) | 2005-03-09 | — | — | CN | disclosed |
| WO-2004007427-A1 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LTD (AU) | 2004-01-22 | — | — | WO | disclosed |
| CN-1358227-A | Preparation of lipidated forms of peptidoglycan-binding lipoproteins of gram-negative bacteria | AMERICAN CYANAMID CO (US) | 2002-07-10 | — | — | CN | disclosed |
| CN-1244126-A | Universal T-cell epitopes for anti-malarial vaccines | UNIV NEW YORK (US) | 2000-02-09 | — | — | CN | disclosed |
| US-5632982-A | Cytotoxic enhancement of TNF with copper | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1997-05-27 | — | — | US | disclosed |
| EP-0080944-A1 | Cephalosporin derivatives substituted in position 3 with a thiomethylheterocyclic group, process for their preparation and pharmaceutical compositions containing them | SANOFI S.A. (FR) | 1983-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170283455-A1 | STABLE TOPICAL PHAMACEUTICAL COMPOSITIONS OF HALOBETASOL PROPIONATE | CYP8B1, CYP51A1, HSD17B7 | NAAA 3498/4885EPHX1 812/4885NOD1 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.